WA People
BILL · 2023–24 SESSION

HB 1642: Cannabis concentrates

Regulating the sale of cannabis concentrates.

Summary

  • Prohibits licensed cannabis retailers from selling cannabis concentrates with a tetrahydrocannabinol (THC) concentration greater than 35 percent, except for cannabis retailers with a medical cannabis endorsement who may continue to sell these products to qualifying patients and designated providers who are entered in the Medical Cannabis Authorization Database.
  • Limits licensed cannabis processors to only processing and selling cannabis concentrates with a THC concentration greater than 35 percent when those products are intended for sale as authorized in the bill.

From the House Bill Analysis 2023 (HB 1642), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 27, 2023
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Lauren Davis (D-32)
Introduced
January 27, 2023 in the House
Last action
January 8, 2024
Budget
Has a fiscal note

AN ACT Relating to addressing serious physical and behavioral health consequences of high-potency cannabis products by regulating the sale of cannabis concentrates;

Sponsors

Prime sponsor: Lauren Davis (D-32)

11 co-sponsors (8 Democrats, 3 Republicans)

Tom Dent R-13Mari Leavitt D-28Paul Harris R-17Lisa Callan D-5Carolyn Eslick R-39Amy Walen D-48Tana Senn D-41Alex Ramel D-40Davina Duerr D-1Mia Gregerson D-33Gerry Pollet D-46

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. First reading, referred to Regulated Substances & Gaming.

HB 1642 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page